A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
Authors
Keywords
Pancreatic cancer, EF24, Combination therapy, Curcumin analogs, Liposomal nanoparticles, Drug delivery
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-11
DOI
10.1186/s12951-016-0209-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
- (2015) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monitoring the Stability of Perfluorocarbon Nanoemulsions by Cryo-TEM Image Analysis and Dynamic Light Scattering
- (2015) Christoph Grapentin et al. PLoS One
- Pegylated liposomal doxorubicin in the management of ovarian cancer
- (2014) Nicoletta Staropoli et al. CANCER BIOLOGY & THERAPY
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: Molecular mechanisms unveiled by gene expression profiling
- (2013) Martin Koch et al. BIOCHEMICAL PHARMACOLOGY
- Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma
- (2013) Yingjian Liang et al. HEPATOLOGY
- Versatile and Efficient Targeting Using a Single Nanoparticulate Platform: Application to Cancer and Alzheimer’s Disease
- (2012) Benjamin Le Droumaguet et al. ACS Nano
- Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts
- (2012) Shijun Zhu et al. Integrative Biology
- Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease
- (2012) Anila Mathew et al. PLoS One
- In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
- (2012) Haitao Liu et al. PLoS One
- Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models
- (2011) Georg Feldmann et al. CANCER BIOLOGY & THERAPY
- Diphenyl Difluoroketone: A Potent Chemotherapy Candidate for Human Hepatocellular Carcinoma
- (2011) Yingjian Liang et al. PLoS One
- Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials
- (2010) Adeeb Shehzad et al. ARCHIV DER PHARMAZIE
- Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro
- (2010) Michaela L. Krieger et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells
- (2010) Murali Mohan Yallapu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model
- (2010) H. Agashe et al. JOURNAL OF NANOPARTICLE RESEARCH
- Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
- (2010) Igor Landais et al. Molecular Cancer
- Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer
- (2010) Savita Bisht et al. MOLECULAR CANCER THERAPEUTICS
- Multiple Anticancer Activities of EF24, a Novel Curcumin Analog, on Human Ovarian Carcinoma Cells
- (2010) Xin Tan et al. Reproductive Sciences
- Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
- (2010) Murali M Yallapu et al. Journal of Ovarian Research
- Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer
- (2009) M. E. Mullendore et al. CLINICAL CANCER RESEARCH
- Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
- (2009) G. Bar-Sela et al. CURRENT MEDICINAL CHEMISTRY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Inhibition of I B Kinase-Nuclear Factor- B Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
- (2008) A. L. Kasinski et al. MOLECULAR PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started